Key result
A retrospective survey was conducted to evaluate various anticoagulant regimens for renal replacement therapy in critically ill patients, though no results are reported in the abstract.
Why the study?
Do different anticoagulant regimens improve mechanical filter life and reduce complications in critically ill patients undergoing renal replacement therapy?
Observational
Yes
Do different anticoagulant regimens improve mechanical filter life and reduce complications in critically ill patients undergoing renal replacement therapy?
A retrospective survey evaluating the efficacy and complications of various anticoagulant regimens for renal replacement therapy in critically ill patients.
Answers are grounded in this paper and cite their sources.
Observational survey of anticoagulants in RRT reports no outcomes; leaves optimal regimen unresolved pending prospective trials.
Anticoagulant drug use is one of the methods employed to prolong filter life during renal replacement therapy in the critically ill patient. In the Mid Trent Critical Care network, a variety of anticoagulant regimens are used with varying efficacy. This is a retrospective survey of anticoagulant regimens, comparing mechanical filter life, blood product use and documented complications in the five largest units using renal replacement therapy in the region, and to evaluate how effective our regimens were compared to standards defined in the medical literature.
No takes yet. Share an insight, caveat, or question.
Sharman et al. (2010) conducted an observational in Critically ill requiring renal replacement therapy. Anticoagulant regimens was evaluated on Mechanical filter life, blood product use and documented complications. A retrospective survey was conducted to evaluate various anticoagulant regimens for renal replacement therapy in critically ill patients, though no results are reported in the abstract.
Synapse has enriched 10 related papers. Consider them for comparative context: